Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $715.8 million.

  • Surgery Partners' Operating Expenses rose 88.79% to $715.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 824.51%. This contributed to the annual value of $2.8 billion for FY2024, which is 1449.92% up from last year.
  • Latest data reveals that Surgery Partners reported Operating Expenses of $715.8 million as of Q3 2025, which was up 88.79% from $714.5 million recorded in Q2 2025.
  • Surgery Partners' 5-year Operating Expenses high stood at $737.3 million for Q4 2024, and its period low was $448.1 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $602.2 million, with a median of $612.9 million in 2022.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 4660.61% in 2021, then surged by 88.79% in 2025.
  • Over the past 5 years, Surgery Partners' Operating Expenses (Quarter) stood at $495.4 million in 2021, then rose by 23.72% to $612.9 million in 2022, then grew by 3.44% to $634.0 million in 2023, then rose by 16.29% to $737.3 million in 2024, then decreased by 2.92% to $715.8 million in 2025.
  • Its Operating Expenses stands at $715.8 million for Q3 2025, versus $714.5 million for Q2 2025 and $714.1 million for Q1 2025.